Cellosaurus cell line ZJU-1127 (CVCL

Cellosaurus ZJU-1127 (CVCL_XC11)

Cross-references
Cell line name	ZJU-1127
Accession	CVCL_XC11
Resource Identification Initiative	To cite this cell line use: ZJU-1127 (RRID:CVCL_XC11)
Comments	Group: Patented cell line. Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017172. Population: Chinese. Doubling time: 18.8 hours (Patent=CN108034636B). Derived from site: In situ; Breast; UBERON=UBERON_0000310.
Sequence variations	Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asn (c.376T>A); ClinVar=VCV000428871; Zygosity=Unspecified (PubMed=30140169).
Disease	Invasive breast carcinoma of no special type (NCIt: C4194)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual	CVCL_XC10 ! ZJU-0725
Sex of cell	Female
Age at sampling	65Y
Category	Cancer cell line
Publications	PubMed=30140169; DOI=10.1186/s12935-018-0617-9; PMCID=PMC6098622 Zhou F., Zhang Y.-H., Xu X.-F., Luo J.-F., Yang F., Wang L.-B., Xie S.-D., Sun J.-H., Yang X.-M. Establishment and characterization of three stable basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53. Cancer Cell Int. 18:118.1-118.15(2018) Patent=CN108034636B Sun J.-H., Yang X.-M., Zhou F., Zhang Y.-H. Human breast cancer cell lines and application. Patent number CN108034636B, 11-Jan-2019
Cell line databases/resources	cancercelllines; CVCL_XC11 CCRID; 4201PAT-CCTCC01126
Encyclopedic resources	Wikidata; Q98136536
Entry history
Entry creation	06-Sep-2019
Last entry update	19-Dec-2024
Version number	9